Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04672863

Mediterranean Diet Post-liver Transplantation

The purpose of this study is to study the effects of a structured Mediterranean dietary program on prevention of weight gain, promotion of heart health and prevention of fatty liver disease after liver transplantation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location status: Recruiting

Location contact

Kymberly Watt, MD

CONTACT

[email protected]

5072661586

About this study

Study Hypotheses

  • A modified Mediterranean diet after liver transplantation results in weight loss, improvement of insulin sensitivity, lipid profiles, blood pressure, BMI, and waist circumference in patients who adhere to the program.
  • A modified Mediterranean diet after liver transplantation results in relative improvement in cardiovascular outcomes in patients who adhere to the program when compared to standard of care.
  • A modified Mediterranean diet after liver transplantation results in relative improvement in 10-year ASCVD risk in patients who adhere to the program when compared to standard of care.
  • A modified Mediterranean diet after liver transplantation decreases the risk of development of NAFLD/NASH/NASH fibrosis in patients who adhere to the program.

Study Design:

  • Single-center, prospective, randomized interventional trial
  • All eligible post-liver transplant patients during the enrollment period will be invited to participate in the trial.
  • All enrolled patients will be randomized to the Dietary Intervention (DI) arm or the Standard of Care (SOC) arm.
  • All patients will be followed for 12 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients ≥ 18 years of age undergoing primary liver transplant
  • Ascites-adjusted BMI ≥ 25 kg/m2
  • Acceptable graft function (total bilirubin level < 5 mg/dL and doppler ultrasound with patent hepatic artery, hepatic veins and portal veins)

Exclusion criteria

  • Hepatocellular carcinoma (HCC) that did not fulfill Milan criteria as per explant histology
  • Untreated post-transplant vascular complications or biliary strictures
  • Multi-organ transplantation
  • Urine protein excretion ≥2.0 g/day
  • Uncontrolled diabetes mellitus (HbA1c > 10%)
  • Associated medical conditions incompatible with safe participation in a nutritional intervention study, including digestive diseases with fat intolerance, neurological, psychiatric or endocrine disorders
  • Active eating disorder (e.g. bulimia nervosa, anorexia nervosa)
  • History of bariatric surgery
  • Pregnancy or planning on pregnancy in the next year

Treatment and study plan

Dietary intervention

Behavioral

Modified Mediterranean diet approved by the Nutrition Team at the Transplant Center and it emphasizes consumption of fruits, vegetables, whole grains, beans and nuts, in addition to low salt (2-2.4g/day), moderate amounts of lean protein (primarily fish and poultry) in addition to low to moderate quantities of monounsaturated fats. The modifications to the traditional Mediterranean diet are: no alcohol consumption and fewer added fats. In addition, close scheduled followup on diet and progress with study team.

Primary outcomes

  1. weight gain

    Time frame: 4 months

    weight in kilograms

  2. weight gain

    Time frame: 12 months

    weight in kilograms

Secondary outcomes

  1. fat mass changes

    Time frame: 4 months

    InBody body composition analysis of fat mass vs lean body mass changes

  2. fat mass changes

    Time frame: 12 months

    InBody body composition analysis of fat mass vs lean body mass changes

Study contacts

Contact information is provided by the study sponsor or research team.

Kymberly Watt, MD

CONTACT

[email protected]

507-266-1586

Mohammad Qasim Khan, M.B.B.S.

CONTACT

[email protected]

507-284-3917

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Effects of a Structured, Modified Mediterranean Dietary Intervention After Liver Transplantation

Important dates

Study start
2021
Primary completion
2027
Study completion
2027
First posted
Dec 17, 2020
Registry last updated
Jan 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.